North Shore Long Island Jewish Health System — New Hyde Park, New York

North Shore Long Island Jewish Health System is a clinical research site located in New Hyde Park, New York, United States 11040.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

North Shore Long Island Jewish Health System has participated in 3 clinical trials.

Therapeutic areas: Crohn Disease, Pulmonary Arterial Hypertension, Asthma.

Sponsors: Celgene, Actelion, Pfizer.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Shore Long Island Jewish Health System?

North Shore Long Island Jewish Health System has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Shore Long Island Jewish Health System conducted?

North Shore Long Island Jewish Health System has 3 clinical trials on record. Their work covers Crohn Disease, Pulmonary Arterial Hypertension, Asthma.

Is North Shore Long Island Jewish Health System accredited by Crixeo Health?

North Shore Long Island Jewish Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Shore Long Island Jewish Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.